-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ballin Brother "Yang Gao Ginseng" provides good advice for Shanghai again!
Shanghai, October 8, 2022 /PRNewswire/ -- On October 7, Mr.
Hubertus von Baumbach, Chairman of the Global Executive Board of Boehringer Ingelheim, was invited to attend the 34th Shanghai Mayor's International Entrepreneur Advisory Conference (IBLAC) and worked with world-renowned multinational business leaders to provide suggestions and suggestions
for Shanghai's urban construction and high-quality economic and social development around the theme of this year's conference, "Promoting Green and Low-carbon Sustainable Development of Cities" 。 This is also the second consecutive year that Mr.
Feng Baohe has represented Boehringer Ingelheim in the "Phase One" with IBLAC
.
This year, Mr.
Feng Baohe put forward "golden ideas" for promoting the green and low-carbon transformation of Shanghai's biomedical industry and building a "healthy Shanghai" around the sub-topic of "Corporate ESG (Environmental, Social and Governance) Practice to Promote Green and Low-Carbon Transformation", combined with Boehringer Ingelheim's strategic framework of "Sustainable Development for Generations to Come"
.
Mr.
Feng Baohe expressed the hope that Shanghai will learn from global best practices, further develop renewable energy and carbon reduction technologies, and gradually build Shanghai into a global highland
for green and low-carbon construction of biopharmaceutical enterprises.
During the meeting, Mr.
Feng Baohe also put forward his own insights
for Shanghai's continuous expansion of opening up, optimization of the business environment, and building a "Shanghai brand" in the world.
As a century-old family company, the concept of sustainability is deeply rooted in Boehringer Ingelheim's corporate DNA
.
In 2021, Boehringer Ingelheim will integrate all sustainability-related initiatives at the company level into a global collaborative network, the "Sustainable development for generations" strategy, which encompasses the pillars
of "more health", "more potential" and "more green".
Boehringer Ingelheim is committed to carbon neutrality in its global operations by 2030
.
As an important pilot project under the company's global sustainable development strategy, Boehringer Ingelheim is located in Shanghai Zhangjiang's human drug production base -- Shanghai Boehringer Ingelheim Pharmaceutical Co.
, Ltd.
achieved carbon peak in 2014, made a comprehensive decarbonization top-level design from energy use, production and manufacturing process and logistics management, and achieved the zero carbon goal in June this year, becoming the first carbon neutral plant
in China's pharmaceutical industry to be certified by domestic and foreign authorities.
The Shanghai Mayor's International Entrepreneur Advisory Conference (IBLAC) began in the late 1980s
.
Over the past 30 years, every year in the golden autumn, a group of internationally renowned entrepreneurs will gather at IBLAC, adhering to the original intention of integrating the wisdom of the world to develop Shanghai, and continuously contributing outstanding international experience
to Shanghai.